Hypertensive Heart Disease Latest Advances

Trilobatin, a Natural Dihydrochalcone, Stabilizes Nrf2 to Protect the Heart from Angiotensin II-Induced Oxidative and Hypertrophic Stress.

Journal: Antioxidants & redox signaling

Published: August 27, 2026

Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index.

Journal: Cureus

Published: August 03, 2026

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

Journal: Lancet (London, England)

Published: July 01, 2026

A novel convolution-transformer model for differentiating hypertrophic cardiomyopathy from Phenocopies using cardiac MRI.

Journal: Magnetic resonance imaging

Published: June 02, 2026

Hypertensive Heart Disease: Risk Marker or Causal Substrate of Heart Failure?

Journal: The American journal of cardiology

Published: June 01, 2026

Impact of Left Ventricular Mass Index and Geometric Pattern on Right Ventricular Dimensions and Function in Hypertensive Patients Using Dual-Source Computed Tomography.

Journal: Cureus

Published: May 27, 2026

Epidemiological and Clinical Profile of Heart Failure at the Morafeno University Hospital of Toamasina, Madagascar: A Three-Year Retrospective Study.

Journal: Cureus

Published: May 24, 2026

The Ibadan Chronic Heart Failure Project: Baseline Clinical Profile, Management, and Six-Month Outcomes of the First 1,290 Participants.

Journal: West African journal of medicine

Published: May 24, 2026

Factors associated with short-term adverse events in hypertensive acute heart failure.

Journal: Acta cardiologica

Published: May 20, 2026

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.

Journal: American journal of physiology. Heart and circulatory physiology

Published: May 19, 2026

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.

Journal: American journal of physiology. Heart and circulatory physiology

Published: May 19, 2026

Hypertensive Heart Disease Latest Advances

Find the Latest Research About Hypertensive Heart Disease

Trilobatin, a Natural Dihydrochalcone, Stabilizes Nrf2 to Protect the Heart from Angiotensin II-Induced Oxidative and Hypertrophic Stress.

Trilobatin, a Natural Dihydrochalcone, Stabilizes Nrf2 to Protect the Heart from Angiotensin II-Induced Oxidative and Hypertrophic Stress.

Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index.

Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index.

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

A novel convolution-transformer model for differentiating hypertrophic cardiomyopathy from Phenocopies using cardiac MRI.

A novel convolution-transformer model for differentiating hypertrophic cardiomyopathy from Phenocopies using cardiac MRI.

Hypertensive Heart Disease: Risk Marker or Causal Substrate of Heart Failure?

Hypertensive Heart Disease: Risk Marker or Causal Substrate of Heart Failure?

Impact of Left Ventricular Mass Index and Geometric Pattern on Right Ventricular Dimensions and Function in Hypertensive Patients Using Dual-Source Computed Tomography.

Impact of Left Ventricular Mass Index and Geometric Pattern on Right Ventricular Dimensions and Function in Hypertensive Patients Using Dual-Source Computed Tomography.

Epidemiological and Clinical Profile of Heart Failure at the Morafeno University Hospital of Toamasina, Madagascar: A Three-Year Retrospective Study.

Epidemiological and Clinical Profile of Heart Failure at the Morafeno University Hospital of Toamasina, Madagascar: A Three-Year Retrospective Study.

The Ibadan Chronic Heart Failure Project: Baseline Clinical Profile, Management, and Six-Month Outcomes of the First 1,290 Participants.

The Ibadan Chronic Heart Failure Project: Baseline Clinical Profile, Management, and Six-Month Outcomes of the First 1,290 Participants.

Factors associated with short-term adverse events in hypertensive acute heart failure.

Factors associated with short-term adverse events in hypertensive acute heart failure.

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.